Access cutting-edge b-cell non-hodgkin lymphoma treatment through this clinical trial at a research site in Eau Claire. Study-provided care at no cost to qualified participants.
Access b-cell non-hodgkin lymphoma specialists in Eau Claire at no cost
This study follows strict safety protocols and ethical guidelines
All study-related b-cell non-hodgkin lymphoma treatment provided free
This phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patients with aggressive B-cell non-Hodgkin lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). Patients that are able to receive CAR T-cell therapy have a potential for cure, however, many will not be qualified to receive therapy due to relapse. Bridging therapy is th
Sponsor: Mayo Clinic
Check if you qualify for this b-cell non-hodgkin lymphoma clinical trial in Eau Claire, WI
If you're searching for b-cell non-hodgkin lymphoma treatment options in Eau Claire, WI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Eau Claire research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-cell non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.